VK CO Ltd/ US5603172082 /
2022-03-02 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.9011USD | - | 605 Turnover: - |
-Bid Size: - | -Ask Size: - | 1.45 bill.USD | - | - |
GlobeNewswire
04-18
Vallourec progresses its holistic balance sheet refinancing with successful pricing of its 2032 Seni...
GlobeNewswire
04-08
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
GlobeNewswire
03-22
Johnson Fistel, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investig...
GlobeNewswire
03-12
Vallourec continues to implement its strategic plan with the arrival of ArcelorMittal, new referenc...
GlobeNewswire
02-13
HIMALAYA TECHNOLOGIES ADDS FORTUNE 100 TELECOMMUNICATIONS EXECUTIVE TO ADVISORY BOARD; COMPANY TARGE...
GlobeNewswire
02-08
Vallourec Secures Significant Purchase Order from Wintershall Dea for Premium Tubular Solutions in t...
GlobeNewswire
2023-12-13
Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies ...
GlobeNewswire
2023-12-07
Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (AL...
GlobeNewswire
2023-11-21
Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years fo...
GlobeNewswire
2023-11-14
PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-11-13
Aligos Therapeutics Presents Clinical and Nonclinical Data at the AASLD Liver Meeting® 2023 Demonstr...
GlobeNewswire
2023-09-06
AgEagle Launches the New eBee VISION Drone; Now Accepting Orders from Customers Worldwide
GlobeNewswire
2023-08-31
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...